• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致与PARK8相关帕金森病的含突变基因的克隆。

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

作者信息

Paisán-Ruíz Coro, Jain Shushant, Evans E Whitney, Gilks William P, Simón Javier, van der Brug Marcel, López de Munain Adolfo, Aparicio Silvia, Gil Angel Martínez, Khan Naheed, Johnson Janel, Martinez Javier Ruiz, Nicholl David, Martí Carrera Itxaso, Pena Amets Saénz, de Silva Rohan, Lees Andrew, Martí-Massó José Félix, Pérez-Tur Jordi, Wood Nick W, Singleton Andrew B

机构信息

Unitat de Genètica Molecular, Departament de Genòmica i Proteòmica, Institut de Biomedicina de València-CSIC, E46010 València, Spain.

出版信息

Neuron. 2004 Nov 18;44(4):595-600. doi: 10.1016/j.neuron.2004.10.023.

DOI:10.1016/j.neuron.2004.10.023
PMID:15541308
Abstract

Parkinson's disease (PD; OMIM #168600) is the second most common neurodegenerative disorder in the Western world and presents as a progressive movement disorder. The hallmark pathological features of PD are loss of dopaminergic neurons from the substantia nigra and neuronal intracellular Lewy body inclusions. Parkinsonism is typically sporadic in nature; however, several rare familial forms are linked to genetic loci, and the identification of causal mutations has provided insight into the disease process. PARK8, identified in 2002 by Funayama and colleagues, appears to be a common cause of familial PD. We describe here the cloning of a novel gene that contains missense mutations segregating with PARK8-linked PD in five families from England and Spain. Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor.

摘要

帕金森病(PD;OMIM #168600)是西方世界第二常见的神经退行性疾病,表现为进行性运动障碍。PD的标志性病理特征是黑质中多巴胺能神经元的丧失和神经元细胞内路易小体包涵体。帕金森症本质上通常是散发性的;然而,几种罕见的家族形式与基因位点相关,因果突变的鉴定为疾病过程提供了深入了解。2002年,船山及其同事鉴定出的PARK8似乎是家族性PD的常见病因。我们在此描述了一个新基因的克隆,该基因包含错义突变,在来自英格兰和西班牙的五个家族中与PARK8相关的PD共分离。由于在PD中观察到震颤,并且一些家族是巴斯克血统,我们将这种蛋白质命名为dardarin,源自巴斯克语单词dardara,意为震颤。

相似文献

1
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.导致与PARK8相关帕金森病的含突变基因的克隆。
Neuron. 2004 Nov 18;44(4):595-600. doi: 10.1016/j.neuron.2004.10.023.
2
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.编码富含亮氨酸重复激酶2(dardarin,PARK8)的基因发生突变会导致家族性帕金森病:临床、病理、嗅觉及功能影像学和遗传学数据。
Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4.
3
Familial Parkinson's disease: clinical and genetic analysis of four Basque families.家族性帕金森病:四个巴斯克家族的临床与遗传学分析
Ann Neurol. 2005 Mar;57(3):365-72. doi: 10.1002/ana.20391.
4
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.LRRK2基因的突变会导致具有多形性病理特征的常染色体显性帕金森病。
Neuron. 2004 Nov 18;44(4):601-7. doi: 10.1016/j.neuron.2004.11.005.
5
Generation of a human iPSC line (CIBi014-A) from a patient with Parkinson's disease carrying a novel heterozygotic PARK8 (LRRK2) mutation.从一位携带新型杂合性 PARK8(LRRK2)突变的帕金森病患者中生成人诱导多能干细胞系(CIBi014-A)。
Stem Cell Res. 2023 Feb;66:102995. doi: 10.1016/j.scr.2022.102995. Epub 2022 Dec 9.
6
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.一种LRRK2突变作为原PARK8家族帕金森症的病因。
Ann Neurol. 2005 Jun;57(6):918-21. doi: 10.1002/ana.20484.
7
Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients.比利时帕金森病患者富含亮氨酸重复激酶2基因中的始创突变p.R1441C
Eur J Hum Genet. 2008 Apr;16(4):471-9. doi: 10.1038/sj.ejhg.5201986. Epub 2008 Jan 16.
8
[Clinical molecular genetics for PARK8 (LRRK2)].PARK8(LRRK2)的临床分子遗传学
Brain Nerve. 2007 Aug;59(8):839-50.
9
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.α-突触核蛋白、富亮氨酸重复激酶 2 和锰在帕金森病发病机制中的作用。
Neurotoxicology. 2011 Oct;32(5):622-9. doi: 10.1016/j.neuro.2011.01.003. Epub 2011 Jan 14.
10
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.携带LRRK2基因相关帕金森病家族的临床和病理特征。
J Neural Transm Suppl. 2006(70):221-9. doi: 10.1007/978-3-211-45295-0_34.

引用本文的文献

1
Systematic review of electron transfer study in DNA relevant to Parkinson's disease and scanning tunneling microscopy.与帕金森病相关的DNA中电子转移研究及扫描隧道显微镜的系统综述。
PeerJ. 2025 Aug 20;13:e19807. doi: 10.7717/peerj.19807. eCollection 2025.
2
The quest for Parkinson's disease biomarkers: traditional and emerging multi-omics approaches.帕金森病生物标志物的探索:传统与新兴的多组学方法
Mol Biol Rep. 2025 Aug 16;52(1):831. doi: 10.1007/s11033-025-10929-x.
3
14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state.
14-3-3蛋白结合可使帕金森相关激酶LRRK2维持在非活性状态。
Nat Commun. 2025 Aug 5;16(1):7226. doi: 10.1038/s41467-025-62337-1.
4
Derailed degradation: LRRK2-dependent exocytosis in Parkinson's disease.脱轨的降解:帕金森病中依赖LRRK2的胞吐作用。
Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2515758122. doi: 10.1073/pnas.2515758122. Epub 2025 Aug 4.
5
Association of LRRK2 R1628P variant with Parkinson's disease in Kinh Vietnamese: a cross-sectional study.越南京族中LRRK2基因R1628P变异与帕金森病的关联:一项横断面研究。
Neurogenetics. 2025 Jul 31;26(1):56. doi: 10.1007/s10048-025-00840-9.
6
LRRK2 kinase modulates glucose-stimulated insulin secretion via RAB8 phosphorylation and ciliogenesis.富含亮氨酸重复激酶2(LRRK2)通过RAB8磷酸化和纤毛生成调节葡萄糖刺激的胰岛素分泌。
Cell Mol Life Sci. 2025 Jul 17;82(1):276. doi: 10.1007/s00018-025-05810-w.
7
Accumulation of LRRK2-associated phospho-Rab12 degenerative lysosomes in tauopathies.富含亮氨酸重复激酶2相关磷酸化Rab12的退行性溶酶体在tau蛋白病中的积累。
bioRxiv. 2025 Jun 9:2025.06.06.658328. doi: 10.1101/2025.06.06.658328.
8
Recent advances in targeting LRRK2 for Parkinson's disease treatment.针对帕金森病治疗靶向亮氨酸丰富重复激酶2(LRRK2)的最新进展。
J Transl Med. 2025 Jul 8;23(1):754. doi: 10.1186/s12967-025-06354-0.
9
Driving Therapeutic Innovation in Neurodegenerative Disease With Hydrogen Deuterium eXchange Mass Spectrometry.利用氢氘交换质谱法推动神经退行性疾病的治疗创新
Mol Cell Proteomics. 2025 Jun 20;24(8):101017. doi: 10.1016/j.mcpro.2025.101017.
10
Structural biology of Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2).帕金森病相关富含亮氨酸重复激酶2(LRRK2)的结构生物学
J Biol Chem. 2025 Jun 14;301(8):110376. doi: 10.1016/j.jbc.2025.110376.